Pitcairn CO Corcept Therapeutics Inc Transaction History
Pitcairn CO
- $1.5 Billion
- Q2 2025
A detailed history of Pitcairn CO transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Pitcairn CO holds 4,161 shares of CORT stock, worth $373,865. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,161
Previous 9,229
54.91%
Holding current value
$373,865
Previous $677,000
54.95%
% of portfolio
0.02%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding CORT
# of Institutions
467Shares Held
82.8MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.49 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$870 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$694 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$563 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$348 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $9.62B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...